本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enlivex Therapeutics Ltd.

1.04
-0.0100-0.95%
盘后1.03-0.0100-0.96%19:26 EDT
成交量:3.86万
成交额:4.13万
市值:2,459.70万
市盈率:-1.42
高:1.07
开:1.06
低:1.03
收:1.05
数据加载中...
2019/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/07/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/04/23

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2018/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2017/12/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2017/11/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2017/11/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2017/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2017/09/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]